This page shows the latest Proteomics news and features for those working in and with pharma, biotech and healthcare.
As part of the study, scientists carried out ‘proteomic’ analyses and observed changes in 52 key proteins and their interaction with each other in response to drug treatments.
launched a biomarker and proteomics alliance with the Medicines Discovery Catapult.
Will also advance proteomics research. The UK’s Medicines Discovery Catapult has teamed up with LifeArc in a bid to develop novel biomarkers and optimise the medical charity's drug development. ... This new post-doc will centre around proteomics, the
The acquisition of Abide provides us with a differentiated chemo-proteomic platform to discover new classes of drugs for a broad spectrum of brain diseases starting with those that harness the
The Swiss pharma giant has been working with proteomics specialist Biognosys to on a mock trial to explore how the technology could be used in clinical investigations, and says its result ... Proteomics was one technology name-checked by outgoing FDA
example based on clinical laboratory, genomic, and proteomic factors, which could reduce the scale and duration of trials.
More from news
Approximately 1 fully matching, plus 18 partially matching documents found.
The science of ‘omics’ – genomics, proteomics, metabolomics – has already taught us that the Big C is far from a singular entity, but is more like thousands of individual diseases caused by
analysis of ‘big data’, genomic and proteomic diagnosis and personalised medicine.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
He also served as president of ProteoPlex, a seed stage spinout focusing on proteomics, which was acquired by Merck KGaA in 2003, and founded Genomes Systems, acquired by Incyte Genomics in
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Joshua Yang, Co-founder &CEO of Glyphic Biotechnologies and Co-founder of NephroSant, dives into next-generation protein sequencing for biomedical research and clinical medicine, his journey from academia to entrepreneurship, and much more.
With a background in Advanced Genomic and Proteomic Sciences, he decided to channel his knowledge into supporting clinical research clients solve their complex problems.
JPT Peptide Technologies GmbH is a leading provider of innovative peptide-based services, and catalog products &kits, as well as a research and development partner for projects in Immunotherapy, Immunology, Proteomics
Creative Proteomics provides a comprehensive range of proteomics services using both gel-based and gel-free proteome analysis platforms. ... We offer quality proteomics services for target identification, lead optimization and preclinical and clinical
More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...